Texas lawsuit over drugs and vaccines provided by insurers ends with a win for the government — and HHS Secretary Robert F.

US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.